Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

Ben M. Eyck(Erasmus MC Cancer Institute), Maurice J.C. van der Sangen(Radboud University Nijmegen), Ernst Jan Spillenaar Bilgen(Radboud University Nijmegen), Geke A.P. Hospers(University Medical Center Groningen), Mark I. van Berge Henegouwen(University of Namur), Jannet C. Beukema(University Medical Center Groningen), Geert-Jan Creemers, Tom Rozema(Radboud University Nijmegen), R.J.B. Blaisse(Rijnstate Hospital), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Joël Shapiro(The Netherlands Cancer Institute), Grard A. P. Nieuwenhuijzen(Radboud University Nijmegen), Olivier R. Busch(Amsterdam Neuroscience), Cornelis J.A. Punt(Utrecht University), Johannes J. Bonenkamp, Miguel A. Cuesta(Hospital General Universitario de Albacete), Pieter van Hagen(Erasmus MC), Janny G. Reinders(Dutch Art Institute), J. Jan B. van Lanschot(Erasmus MC Cancer Institute), John Th. M. Plukker(University Medical Center Groningen), Maarten C.C.M. Hulshof(Academic Medical Center), Henk M.W. Verheul(Erasmus MC Cancer Institute), Ewout W. Steyerberg(Erasmus MC), Hanneke W. M. van Laarhoven(Dutch Cancer Society), Anna H.M. Piet(Amsterdam University Medical Centers), Ate van der Gaast(Erasmus MC), Hugo W. Tilanus(Amsterdam UMC Location University of Amsterdam), Caroline M. van Rij(Erasmus MC), Berend J. van der Wilk(Erasmus MC Cancer Institute), Fiebo J.W. ten Kate
Journal of Clinical Oncology
April 23, 2021
Cited by 788


Related Papers